Sequential allogeneic and autologous CAR-T-cell therapy to treat an immune-compromised leukemic patient.

ABSTRACT:

SUBMITTER: Zhang JP 

PROVIDER: S-EPMC6058233 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature